Mike Mencer

Mike Mencer, PMP, is the Executive Vice President and General Manager, Early Phase, at Worldwide Clinical Trials. Mike’s 25+ years in drug development and research comprise both scientific expertise and business acumen. Today, his strategic leadership of Worldwide’s Early Phase team ensures sponsors are well-positioned to pursue the study of their novel therapies.

Posts by Mike Mencer

MedCity Influencers

Continuous Process Improvement: The Secret to Navigating Early-Phase Drug Development

Deploying a robust continuous improvement methodology is especially beneficial in the earliest phases of drug development. It can help ensure the delivery of high-quality, reliable, timely bioanalytical and clinical data to make informed decisions about either moving on to the next drug development milestone or pivoting to another strategy.

Mike Mencer

Posts by Mike Mencer

Continuous Process Improvement: The Secret to Navigating Early-Phase Drug Development

Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use to Rare Blood Vessel Disorder

Why HIPAA Compliance Is Both a Challenge and Opportunity for EMS Providers

For the Sake of their Constituents, Congress Should Increase Medicare Payments and Oppose Deep Cuts to Medicaid